Clinical Trial Update: IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing intravenous ferric carboxymaltose to oral iron for treatment of iron-deficiency anemia at delivery in Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Oral iron (ferrous sulfate)

Snippet

Sponsor: Ifakara Health Institute | Conditions: Iron-Deficiency Anemia | Phase 3 | Status: UNKNOWN